This is the text extract for November Tender Notification, browse documents here.

---

30 November 2010

TENDER RESULTS

The PHARMAC Board (or Chief Executive under delegated authority) has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2008/09 Invitation to Tender, dated 23 December 2008 and the 2009/10 Invitation to Tender, dated 4 December 2009. Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted. Notification of Product Changes (NOPC) forms Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the price change/listing taking effect. More information and NOPC forms can be found on our website – www.pharmac.govt.nz/schedule.asp. 2008/09 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 1. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (or subsidy reduction) for tender winning brand at the tender subsidy will occur on 1 May 2011; reference pricing of non-tender winning brands will occur on 1 July 2011; Sole Subsidised Supply commences on 1 October 2011; delisting of other brands in Section B will occur on 1 October 2011.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Inj 50 mcg per ml, 2 ml; 10 ampoules Inj 50 mcg per ml, 10 ml; 10 ampoules

Sole Supply Brand (Supplier) Boucher and Muir Boucher and Muir

Current subsidy and price $6.10 (5 ampoules) $15.65 (5 ampoules)

New subsidy and price $6.43 $16.81

Brand (Supplier) affected by reference pricing and delisting Hospira Hospira

Fentanyl citrate Fentanyl citrate

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 2. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price change for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 May 2011; Hospital Supply Status and DV Limits will apply from 1 July 2011; delisting of other brands in Section H will occur on 1 July 2011.

The decisions were as follows:

Chemical Name Fentanyl citrate

Presentation; Pack size and type Inj 50 mcg per ml, 2 ml; 10 ampoules

Hospital Supply Brand (Supplier) Boucher and Muir

Current pack price $6.10 (5 ampoules)

New pack DV Brand (Supplier) to be delisted price Limit $6.43 1% Hospira

A370926 - qA15909

---

Chemical Name Fentanyl citrate

Presentation; Pack size and type Inj 50 mcg per ml, 10 ml; 10 ampoules

Hospital Supply Brand (Supplier) Boucher and Muir

Current pack price $15.65 (5 ampoules)

New pack DV Brand (Supplier) to be delisted price Limit $16.81 1% Hospira

2009/10 Tender Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule 3. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (or subsidy reduction) for tender winning brand at the tender subsidy will occur on 1 January 2011; Sole Subsidised Supply commences on 1 June 2011; delisting of other brands in Section B will occur on 1 June 2011.

The decisions were as follows:

Chemical Name

Presentation; Pack size and type Oral liq 10 g per 15 ml; 1000 ml bottle

Sole Supply Brand (Supplier) Laevolac (Douglas)

Current subsidy and price $6.65

New subsidy and price $7.68

Brand (Supplier) affected by reference pricing and delisting Duphalac (Healthcare Logistics)

Lactulose*

* Note that due to the price increase on lactulose, the Duphalac brand will not be reference priced to the Laevolac brand. The Duphalac brand will remain listed at the current subsidy ($6.65 per 1000 ml bottle) until 1 June 2011.

4. Tenders awarded to pharmaceuticals where at least one other brand is listed – listing (or subsidy reduction) for tender winning brand at the tender subsidy will occur on 1 May 2011; reference pricing of non-tender winning brands will occur on 1 July 2011; Sole Subsidised Supply commences on 1 October 2011; delisting of other brands in Section B will occur on 1 October 2011.

The decisions were as follows:

Chemical Name Compound electrolytes

Presentation; Pack size and type Powder for soln for oral use 4.4 g; 5 sachets

Sole Supply Brand (Supplier) Electral (Arrow)

Current subsidy and price $2.86 (10 sachets)

New subsidy and price $1.12

Brand (Supplier) affected by reference pricing and delisting Enerlyte (Multichem)

Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule 5. Tenders awarded to pharmaceuticals where no brand is listed - listing of the hospital tender winning brand of the pharmaceuticals will occur in Part II of Section H of the Pharmaceutical Schedule on 1 January 2011; Hospital Supply Status and DV Limits will apply from 1 March 2011.

The decisions were as follows:

Chemical Name Rocuronium bromide

Presentation; Pack size and type Inj 10 mg per ml, 5 ml; 10 injections, vial

Hospital Supply Brand (Supplier) Arrow-Rocuronium (Arrow)

Pack price $85.00

DV Limit 1%

6. Tenders awarded to listed pharmaceuticals where an alternative brand is already listed – price change for the hospital tender winning brand of the pharmaceutical will occur in Section H of the Pharmaceutical Schedule on 1 January 2011; Hospital Supply Status and DV Limits will apply from 1 March 2011; delisting of other brands in Section H will occur on 1 March 2011.

The decisions were as follows:

Chemical Name Lactulose

Presentation; Pack size and type Oral liq 10 g per 15 ml; 1000 ml bottle

Hospital Supply Brand (Supplier) Laevolac

Current pack price $6.65

New pack price $7.68

DV Limit 1%

Brand (Supplier) to be delisted Duphalac (Healthcare

A370926 - qA15909

Page 2 of 3

---

Chemical Name

Presentation; Pack size and type

Hospital Supply Brand (Supplier) (Douglas)

Current pack price

New pack price

DV Limit

Brand (Supplier) to be delisted Logistics)

For products included in the 2008/09 Invitation to Tender and 2009/10 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or Chief Executive) approval. We will keep you informed of any updates regarding such tender products as decisions are made. If you have any queries regarding this notification please contact PHARMAC on 0800 66 00 50.

A370926 - qA15909

Page 3 of 3